Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP433409.RAU4oRwzQrNsoxRhHznFiNIapOgMqWgP1rYgAQNe8AAzc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP433409.RAU4oRwzQrNsoxRhHznFiNIapOgMqWgP1rYgAQNe8AAzc130_assertion type Assertion NP433409.RAU4oRwzQrNsoxRhHznFiNIapOgMqWgP1rYgAQNe8AAzc130_head.
- NP433409.RAU4oRwzQrNsoxRhHznFiNIapOgMqWgP1rYgAQNe8AAzc130_assertion description "[Loss of GPX1 expression was significantly associated with advanced gastric cancer (p=0.039) and lymphatic invasion (p=0.010); loss of GPX3 expression was associated with advanced gastric cancer (p<0.001) and lymph node metastasis (p<0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433409.RAU4oRwzQrNsoxRhHznFiNIapOgMqWgP1rYgAQNe8AAzc130_provenance.
- NP433409.RAU4oRwzQrNsoxRhHznFiNIapOgMqWgP1rYgAQNe8AAzc130_assertion evidence source_evidence_literature NP433409.RAU4oRwzQrNsoxRhHznFiNIapOgMqWgP1rYgAQNe8AAzc130_provenance.
- NP433409.RAU4oRwzQrNsoxRhHznFiNIapOgMqWgP1rYgAQNe8AAzc130_assertion SIO_000772 22843889 NP433409.RAU4oRwzQrNsoxRhHznFiNIapOgMqWgP1rYgAQNe8AAzc130_provenance.
- NP433409.RAU4oRwzQrNsoxRhHznFiNIapOgMqWgP1rYgAQNe8AAzc130_assertion wasDerivedFrom befree-20150227 NP433409.RAU4oRwzQrNsoxRhHznFiNIapOgMqWgP1rYgAQNe8AAzc130_provenance.
- NP433409.RAU4oRwzQrNsoxRhHznFiNIapOgMqWgP1rYgAQNe8AAzc130_assertion wasGeneratedBy ECO_0000203 NP433409.RAU4oRwzQrNsoxRhHznFiNIapOgMqWgP1rYgAQNe8AAzc130_provenance.